Inhibrx, Inc. (INBX) Misses Q3 EPS by 71c

Inhibrx, Inc. (NASDAQ: INBX) reported Q3 EPS of ($2.28), $0.71 worse than the analyst estimate of ($1.57).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• Deutsche Bank monitors UK auto sales as Chinese exports grow
• S&P 500 may pull back before midterms, but Citi says buy the dip
• Vivakor posts positive operating income as Q2 revenue rises 10%